https://www.cnbc.com/2017/10/30/mer...irms-downgrade-on-cancer-drug-withdrawal.html
What do we think this means for Viraytics. Opportunity or a problem?
- Forums
- ASX - By Stock
- VLA
- Keytruda and Merck article about problems with lung cancer trial.
Keytruda and Merck article about problems with lung cancer trial.
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)